Genetically Engineering Cannabis for the Pharmaceuticals
One way this is already happening is in a secret lab in the South of England, GW Pharmaceuticals, which extracts, refines and studies the plant in their six different greenhouses, where they raise 10,000 plants each. At this undisclosed location, GW uses genetic engineering to create modified varieties and then clones each strain. They are already marketing one of their genetically engineered cannabis products in Canada as a sublingual (under the tongue) spray for treating muscle spasms associated with multiple sclerosis.
If the cloned strains were to cross pollinate with naturally-occurring strains, we could easily see the organic cannabis plants compromised and ultimately eliminated. As the story of GMO corn demonstrates, with companies driven by profit and control, this threat to corner the market is not one we should take lightly. Read the whole article here